Chiral synthesis via organoboranes. 28. Reaction of .alpha.-chiral organyldichloroboranes with organyl azides providing a synthesis of secondary amines with exceptionally high enantiomeric purities
作者:Herbert C. Brown、Ashok M. Salunkhe、Bakthan Singaram
DOI:10.1021/jo00003a046
日期:1991.2
2-Alkyl-1,3,2-dioxaborinanes R*BO2(CH2)3 of essentially 100% enantiomeric purity were prepared by the asymmetric hydroboration of readily available prochiral olefins with mono- or diisopinocampheylboranes, followed by removal of the chiral auxiliary (alpha-pinene). The intermediate R*BO2(CH2)3 reacts readily with lithium aluminum hydride at 0-degrees-C to give the corresponding lithium monoalkylborohydrides stereospecifically in very good yields and in very high enantiomeric purities. The lithium monoalkylborohydrides, on treatment with hydrogen chloride in dimethyl sulfide, give the corresponding monoalkyldichloroboranes in very high enantiomeric purity. The intermediate monoalkyldichloroboranes react readily with organic azides in 1,2-dichloroethane with evolution of gaseous nitrogen and transfer of the organic group from boron to nitrogen with complete retention of configuration to provide the corresponding secondary amines, either (+)- or (-), in very high yields and exceptionally high enantiomeric purities. The procedure was applied to the synthesis of representative optically active amines of high enantiomeric purities (ee or de greater-than-or-equal-to 99%), including (2S,2'S)-di-2-butylamine, N-[(2S)-2-methyl-1-butyl]-(1S,2R)-trans-2-phenycyclopentylamine, N-[(3S)-3,7-dimethyloct-6-enyl](1S,2S)-trans-2-methylcyclohexylamine, and the meso-di-2-butylamine.
Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
申请人:ZAMBON GROUP S.p.A.
公开号:EP0342613B1
公开(公告)日:1992-11-11
DE, AMICI MARCO;DE, MICHELI CARLO;PLATINI, FABIO;DELLA, BELLA DAVIDE;CARA+, EUR. J. MED. CHEM., 23,(1988) N, C. 511-515
The crystal structures of the following three stereoisomers have been determined: (1S)-2-[(1R,1'R)-, (1S)-2-[(1S,1'S)- and (1S)-2-[(1R,1'S)-bis(l-methylpropyl)amino]-1-[(5S)-1- [(2-chlorophenyl)methyl]-2-oxo-5-pyrrolidinyl]ethanol, C21H33ClN2O2 The configurations at the stereocentres strongly influence both the hydrogen-bonding behaviour of the OH group and the packing. The conformations of the central N-C-C(OH)-C-N chains are particularly relevant to this behaviour and to the pharmacological activity.